Seeking Alpha

Halozyme Therapeutics (HALO) hooks up with Pfizer (PFE) to develop and market products combining...

Halozyme Therapeutics (HALO) hooks up with Pfizer (PFE) to develop and market products combining Halozyme's rHuPH20 with Pfizer's proprietary biologics. Halozyme receives an upfront payment of $8M, and future payments of up to $507M will depend on Pfizer's reaching of certain targets. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs